Rheumatoid factor
Tofacitinib Use Linked to Increased Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis
Researchers at Fujian Medical University have conducted a study to assess the association between tofacitinib use and the risk of venous thromboembolism (VTE) events in patients with rheumatoid arthritis (RA). The study, published in Naunyn-Schmiedeberg's Archives of Pharmacology, found that tofacitinib was associated with a significantly elevated risk